{"id":2335,"date":"2018-10-03T15:24:18","date_gmt":"2018-10-03T15:24:18","guid":{"rendered":"http:\/\/ironbridgecp.com\/?post_type=project&#038;p=2335"},"modified":"2020-04-29T09:03:01","modified_gmt":"2020-04-29T09:03:01","slug":"censo-biotechnlogies","status":"publish","type":"avada_portfolio","link":"https:\/\/ironbridgecp.com\/wordpress\/portfolio-items\/censo-biotechnlogies\/","title":{"rendered":"Censo Biotechnlogies"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:calc( 1200px + 0px );margin-left: calc(-0px \/ 2 );margin-right: calc(-0px \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:0px;--awb-margin-bottom-large:0px;--awb-spacing-left-large:0px;--awb-width-medium:100%;--awb-spacing-right-medium:0px;--awb-spacing-left-medium:0px;--awb-width-small:100%;--awb-spacing-right-small:0px;--awb-spacing-left-small:0px;\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-text fusion-text-1\"><p>Partners at Ironbridge participated in the \u00a31.3m capital raise. David Alexander has joined the Board as a non-executive director.<\/p>\n<p>Censo Biotechnologies (<a href=\"http:\/\/www.censobio.com\" target=\"_blank\" rel=\"noopener noreferrer\">www.censobio.com<\/a>) enables the discovery and development of new targeted treatments for disease by using stem cell technology to predict how drugs will behave across a given population.<\/p>\n<\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":2333,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","format":"standard","meta":[],"portfolio_category":[27],"portfolio_skills":[],"portfolio_tags":[],"_links":{"self":[{"href":"https:\/\/ironbridgecp.com\/wordpress\/wp-json\/wp\/v2\/avada_portfolio\/2335"}],"collection":[{"href":"https:\/\/ironbridgecp.com\/wordpress\/wp-json\/wp\/v2\/avada_portfolio"}],"about":[{"href":"https:\/\/ironbridgecp.com\/wordpress\/wp-json\/wp\/v2\/types\/avada_portfolio"}],"author":[{"embeddable":true,"href":"https:\/\/ironbridgecp.com\/wordpress\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ironbridgecp.com\/wordpress\/wp-json\/wp\/v2\/comments?post=2335"}],"version-history":[{"count":2,"href":"https:\/\/ironbridgecp.com\/wordpress\/wp-json\/wp\/v2\/avada_portfolio\/2335\/revisions"}],"predecessor-version":[{"id":2558,"href":"https:\/\/ironbridgecp.com\/wordpress\/wp-json\/wp\/v2\/avada_portfolio\/2335\/revisions\/2558"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ironbridgecp.com\/wordpress\/wp-json\/wp\/v2\/media\/2333"}],"wp:attachment":[{"href":"https:\/\/ironbridgecp.com\/wordpress\/wp-json\/wp\/v2\/media?parent=2335"}],"wp:term":[{"taxonomy":"portfolio_category","embeddable":true,"href":"https:\/\/ironbridgecp.com\/wordpress\/wp-json\/wp\/v2\/portfolio_category?post=2335"},{"taxonomy":"portfolio_skills","embeddable":true,"href":"https:\/\/ironbridgecp.com\/wordpress\/wp-json\/wp\/v2\/portfolio_skills?post=2335"},{"taxonomy":"portfolio_tags","embeddable":true,"href":"https:\/\/ironbridgecp.com\/wordpress\/wp-json\/wp\/v2\/portfolio_tags?post=2335"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}